The role of patients' families in treatment decision-making among adult cancer patients in the Sultanate of Oman

A. Al-Bahri, M. Al-Moundhri, Z. Al-Mandhari, M. Al-Azri

Research output: Contribution to journalArticle

Abstract

There are limited numbers of studies available in Middle Eastern Arabic countries regarding participation of family members in cancer treatment decision-making (TDM). The aim of this study was to evaluate the role of family members' in TDM among adult Omani cancer patients. A cross-sectional study was conducted in two main teaching hospitals. All adult Omani patients who were diagnosed with cancer and their nominated family members were invited to participate. A tool developed by Cancer Care Outcomes Research and Surveillance Consortium was used to identify the level of family involvement in TDM. A weighted kappa (k) was significant (p < .001) and showed almost full agreement between the patients' experiences and their preferences ( k = .98) and between family members' experiences and their preferences ( k = .96) of family involvement in TDM. Binary logistic regression showed significant family-controlled TDM if the patient communicated less with oncologists (OR = 9.89; 95% CI: 3.79-25.81); financial dependence of the patient on their families (OR = 6.21; 95% CI: 2.19-17.10 ); and advanced stages of cancer at the time of diagnosis (OR = 3.10; 95% CI: 1.37-7.03). Oncologists in Oman should be aware of the strong family involvement in TDM to allow a successful cancer treatment.

Original languageEnglish
JournalEuropean Journal of Cancer Care
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Oman
Decision Making
Neoplasms
Therapeutics
Teaching Hospitals
Cross-Sectional Studies
Logistic Models
Outcome Assessment (Health Care)

Keywords

  • Cancer
  • Decision-making
  • Family members
  • Oman

ASJC Scopus subject areas

  • Oncology

Cite this

@article{875f6940738f405bb90e0efebed3d673,
title = "The role of patients' families in treatment decision-making among adult cancer patients in the Sultanate of Oman",
abstract = "There are limited numbers of studies available in Middle Eastern Arabic countries regarding participation of family members in cancer treatment decision-making (TDM). The aim of this study was to evaluate the role of family members' in TDM among adult Omani cancer patients. A cross-sectional study was conducted in two main teaching hospitals. All adult Omani patients who were diagnosed with cancer and their nominated family members were invited to participate. A tool developed by Cancer Care Outcomes Research and Surveillance Consortium was used to identify the level of family involvement in TDM. A weighted kappa (k) was significant (p < .001) and showed almost full agreement between the patients' experiences and their preferences ( k = .98) and between family members' experiences and their preferences ( k = .96) of family involvement in TDM. Binary logistic regression showed significant family-controlled TDM if the patient communicated less with oncologists (OR = 9.89; 95{\%} CI: 3.79-25.81); financial dependence of the patient on their families (OR = 6.21; 95{\%} CI: 2.19-17.10 ); and advanced stages of cancer at the time of diagnosis (OR = 3.10; 95{\%} CI: 1.37-7.03). Oncologists in Oman should be aware of the strong family involvement in TDM to allow a successful cancer treatment.",
keywords = "Cancer, Decision-making, Family members, Oman",
author = "A. Al-Bahri and M. Al-Moundhri and Z. Al-Mandhari and M. Al-Azri",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/ecc.12845",
language = "English",
journal = "European Journal of Cancer Care",
issn = "0961-5423",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - The role of patients' families in treatment decision-making among adult cancer patients in the Sultanate of Oman

AU - Al-Bahri, A.

AU - Al-Moundhri, M.

AU - Al-Mandhari, Z.

AU - Al-Azri, M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - There are limited numbers of studies available in Middle Eastern Arabic countries regarding participation of family members in cancer treatment decision-making (TDM). The aim of this study was to evaluate the role of family members' in TDM among adult Omani cancer patients. A cross-sectional study was conducted in two main teaching hospitals. All adult Omani patients who were diagnosed with cancer and their nominated family members were invited to participate. A tool developed by Cancer Care Outcomes Research and Surveillance Consortium was used to identify the level of family involvement in TDM. A weighted kappa (k) was significant (p < .001) and showed almost full agreement between the patients' experiences and their preferences ( k = .98) and between family members' experiences and their preferences ( k = .96) of family involvement in TDM. Binary logistic regression showed significant family-controlled TDM if the patient communicated less with oncologists (OR = 9.89; 95% CI: 3.79-25.81); financial dependence of the patient on their families (OR = 6.21; 95% CI: 2.19-17.10 ); and advanced stages of cancer at the time of diagnosis (OR = 3.10; 95% CI: 1.37-7.03). Oncologists in Oman should be aware of the strong family involvement in TDM to allow a successful cancer treatment.

AB - There are limited numbers of studies available in Middle Eastern Arabic countries regarding participation of family members in cancer treatment decision-making (TDM). The aim of this study was to evaluate the role of family members' in TDM among adult Omani cancer patients. A cross-sectional study was conducted in two main teaching hospitals. All adult Omani patients who were diagnosed with cancer and their nominated family members were invited to participate. A tool developed by Cancer Care Outcomes Research and Surveillance Consortium was used to identify the level of family involvement in TDM. A weighted kappa (k) was significant (p < .001) and showed almost full agreement between the patients' experiences and their preferences ( k = .98) and between family members' experiences and their preferences ( k = .96) of family involvement in TDM. Binary logistic regression showed significant family-controlled TDM if the patient communicated less with oncologists (OR = 9.89; 95% CI: 3.79-25.81); financial dependence of the patient on their families (OR = 6.21; 95% CI: 2.19-17.10 ); and advanced stages of cancer at the time of diagnosis (OR = 3.10; 95% CI: 1.37-7.03). Oncologists in Oman should be aware of the strong family involvement in TDM to allow a successful cancer treatment.

KW - Cancer

KW - Decision-making

KW - Family members

KW - Oman

UR - http://www.scopus.com/inward/record.url?scp=85045706124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045706124&partnerID=8YFLogxK

U2 - 10.1111/ecc.12845

DO - 10.1111/ecc.12845

M3 - Article

JO - European Journal of Cancer Care

JF - European Journal of Cancer Care

SN - 0961-5423

ER -